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S48Objectives: Energy-based tissue fusion technology is being increasingly used for vascular division in numerous
intra-abdominal applications. Very few data, however, are available regarding the application of this technology
in the chest during anatomic lung resection. In the present review, we evaluated the use of energy-based fusion
and lung sealants during anatomic lung resection.
Methods: We performed a review of case series and published studies to evaluate the use of energy-based
coagulative fusion technology and lung sealants during anatomic lung resection. We then used energy-based
coagulative fusion technology during anatomic lung resection (segmentectomy or lobectomy) in 316 cases
from 2008 to 2011. Two energy applications were applied to the arterial and venous branches before vessel
division.
Results: In the first 12 cases, we used a device with a small curved jaw (range, 3.3-4.7 mm). Two partial venous
dehiscences were noted and controlled intraoperatively. For the remaining cases, we used a larger jaw
(6 mm 3 22 mm) with no arterial or venous dehiscence occurring (vessels ranged from 0.4 to 1.2 cm). Autol-
ogous or synthetic tissue sealants applied to the parenchymal staple lines might reduce the severity and duration
of perioperative air leaks. Suture line buttressing with pericardial or absorbable biosynthetic polyester strips
might reduce the severity of air leaks in patients with severe emphysema undergoing anatomic lung resection
or lung volume reduction surgery.
Conclusions: The bipolar tissue fusion system provides a safe and effective technique for the division of the
pulmonary arterial and venous branches during anatomic lung resection. Surgical sealants and buttressing
adjuncts might reduce perioperative air leak potential. (J Thorac Cardiovasc Surg 2012;144:S48-51)ENERGY-BASED TISSUE FUSION
During the past 75 years, a remarkable evolution of surgical
techniques has occurred in the management of the pulmo-
nary vasculature during anatomic lung resection. For
many decades, manual ligation by way of open thoracotomy
was required for selective vascular isolation and division.1
With the introduction of minimally invasive thoracoscopic
techniques,2 the endostapler has emerged as the primary
method of dividing both the pulmonary parenchyma and
the vasculature.3,4 The use of staples for control of the
pulmonary vasculature has been shown to achieve secure
closure of the pulmonary artery and vein comparable to
that with manual surgical techniques, with minimal riske Department of Cardiothoracic Surgery, University of Pittsburgh Medical
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The Journal of Thoracic and Cardiovascular Surgof adverse events from the technical application or
mechanical failure.5 In a study of 713 patients undergoing
stapled vascular division of 2567 vessels, vascular compli-
cations included 5 cases of minor intimal fracture, 1 arterial
avulsion, and 1 stapler misfire, with an overall adverse event
rate during stapler application of 0.27%.6
The use of energy to accomplish vascular fusion and di-
vision is now emerging as a viable alternative to the endo-
stapler. Energy-based coagulative and tissue fusion
technology has been applied effectively and has increased
in popularity and use in a wide variety of intra-abdominal
procedures.7 Several energy-based fusion devices are cur-
rently available, including the harmonic scalpel (Ethicon
Endo-Surgery, Cincinnati, Ohio), ultrasonic shears (Covi-
dien, Mansfield, Mass), Gyrus PK Tissue Management Sys-
tem (Gyrus Medical, Minneapolis, Minn), BiClamp
VIO300D Electrosurgical System (ERBE Elektromedizin
GmbH, Tuebingen, Germany), Enseal PTS Tissue Sealing
and Homeostasis System (SurgRx, Redwood City, Calif),
and the Ligasure Device (Valleylab, Boulder, Colo). Cur-
rently, only the Ligasure device has been approved by the
Food and Drug Administration for division of the intratho-
racic vasculature.
The Ligasure system creates a vascular seal by applica-
tion of bipolar electrosurgical radiofrequency energy. Vas-
cular fusion is accomplished by the re-organization of theery c September 2012
Schuchert et al Session IV: Training/Education/Technologycollagen and elastin fibers within the vessel wall using
a combination of heat and pressure to achieve a permanent
seal.8 The microprocessor in the generator monitors the tis-
sue conductance properties, stops the application of energy,
and allows a brief period of cooling before indicating that
the seal cycle is complete. This device is fitted with a central
cutting blade between the 2 coagulative surfaces of the in-
strument, promoting effective coagulative ligation (or seal-
ing) and division of the pulmonary vessel or parenchyma.
Two hand-held instruments are currently available
(Figure 1). The Ligasure Impact (n ¼ 12) is 18 cm long,
with a 14 curved jaw. The seal width measures 3.3 to 4.7
mm. The LigaSure Atlas is 20 cm long and applies a seal
6 mm wide by 22 mm long. The length of the shaft and
the low profile of the jaws facilitate its application during
thoracoscopy. An insulated layer minimizes heat transmis-
sion to the exterior jaw surfaces, minimizing thermal spread
to approximately 2 mm. This device has been approved by
the Food and Drug Administration for fusion and division of
lymphatics, tissue bundles, and pulmonary vasculature up
to 7 mm in size. Two energy applications are typically ap-
plied before vessel division. For pulmonary veins, the
first-order branches are isolated and divided, instead of
the main trunk, because of their thinner wall and decreased
collagen content. Arterial division can be accomplished re-
liably in vessels up to 7 mm in diameter. For larger vessels,
vascular division is recommended at the level of theFIGURE 1. Ligasure handpieces. A, Ligasure Impact and (B) Ligasure
Atlas.
The Journal of Thoracic and Cafirst-order branches (Figure 2). We currently do not advo-
cate the use of the Ligasure for primary parenchymal divi-
sion during anatomic lung resection.
Few published data are currently available regarding the
application of this technology in the division of the pulmo-
nary vasculature during anatomic lung resection. In preclin-
ical swine models, the use of bipolar electrocoagulation
sealing devices has been shown to achieve durable burst
pressures (>300 mm Hg),9 with successful division of pul-
monary vessels less than 5 mm in size.10 In a bovine study
testing the burst pressures of 5-mm arterial vessels treated
with 4 different vascular sealing devices, the Ligasure de-
vice resulted in the greatest burst pressure (385 mm Hg)
and fastest sealing time (10 seconds).11 Lacin and col-
leagues12 studied the efficacy of energy-based fusion during
lobectomy in sheep. No vascular disruption was noted for
vessels less than 9 mm in size.
In humans, the data have been limited to several small
case series. Although initially studied for its application
during parenchymal wedge resection,13 its utility in ana-
tomic lung resection was initially demonstrated in the set-
ting of pediatric14 and robotic15 surgery without adverse
events reported. Santini and associates16 reported on the
use of the Ligasure device during lung resection in 36 pa-
tients, dividing vessels up to 7 mm in size without perioper-
ative bleeding and no mortality. We have previously
reported our experience with the Ligasure device in 211 pa-
tients.17 Using the Ligasure Impact hand piece (n ¼ 12), no
arterial dehiscences were encountered. However, 2 partial
venous dehiscences occurred that were recognized and con-
trolled intraoperatively. The remainder of the cases were
treated with the LigaSure Atlas without vascular dehis-
cence. Vascular division was successfully performed on
476 arterial and 229 venous branches without the need for
hemostatic adjuncts (eg, clips, staples).17 We have now
used energy-based tissue fusion in 316 cases. We encoun-
tered 1 additional case of iatrogenic dehiscence involving
an arterial branch that had undergone previous fusion.
This patient was noted postoperatively to have a hilar hema-
toma that was ultimately found to be secondary to bronchial
artery bleeding. While evacuating the clot, a previously
sealed vessel removed from the primary site of bleeding
partially dehisced secondary to suction trauma and requir-
ing the placement of a clip. No postoperative complications
developed that were directly attributable to the use of the Li-
gasure device.
The use of a single energy device to accomplish vascular
division during anatomic lung resection can reduce the need
to usemultiple reloadable stapler cartridges, leading to a po-
tential reduction in operative costs. The Ligasure device is
priced at US$350. Assuming the average use of 1.5 staplers
per case (US$300 each) and an average stapler cartridge
cost of US$100, the total cost savings of performing the
vascular divisions during lobectomies (average, 3.5rdiovascular Surgery c Volume 144, Number 3 S49
FIGURE 2. A, The Ligasure device is readily introduced through a thoracoscopic port. B, Ligasure application to the apical and anterior superior pulmo-
nary vein. C, Vascular fusion is accomplished with 2 arteries of the left upper division. Black arrow denotes the divided energy applications. D, Arterial
(white arrows) and venous (black arrow) stumps after fusion and division.
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case) with the Ligasure would be about US$400 to
US$600 per case. This does not account for the multiple sta-
ple loads used to develop the fissures that would also be
amenable to division with the Ligasure, potentially increas-
ing the cost savings to as much as US$1000 per patient.
Conclusions
Bipolar tissue fusion systems can be used safely during
the division of both pulmonary arteries and veins
(7 mm) during anatomic lung resection. It can be consid-
ered a valid alternative to stapling technology in this setting.
Larger prospective series with long-term results and cost/
benefit analyses are necessary to better define the utility
of this technology during anatomic lung resection.
LUNG SEALANTS AND BUTTRESSING
TECHNIQUES
Prolonged postoperative air leaks (>7 days) can occur in
15% to 18% of cases after lung resection.18 Numerous
techniques have been explored to help minimize the occur-
rence of this difficult complication, including advances in
stapling technology and the application of various fibrin
and synthetic sealants. Lung sealants are most commonly
applied to the surgical staple lines at the conclusion of the
case prophylactically. The most extensively studied lung
sealant has been fibrin glue (thrombin/fibrinogen). Mixed
at application, fibrin glue creates a clot-like fibrin matrix
over the staple line. It is applied in the hope of minimizing
the egress of air. Studies evaluating the efficacy of fibrinS50 The Journal of Thoracic and Cardiovascular Surgglue to date have reported mixed results. Several early pro-
spective, randomized studies failed to show any effect on
the incidence of postoperative air leak, chest tube duration,
or length of stay.19,20 More recent studies evaluating fibrin
glue and an autologous platelet-rich fibrin sealant (Vivostat
A/S, Alleroed, Denmark), however, have demonstrated a re-
duction in the proportion of patients with postoperative air
leaks.21
Synthetic, bioabsorbable sealants (polyethylene glycol-
based) have alsobeen applied in this setting. Several prospec-
tive, randomized trials have shown a decreased incidence of
air leaks with polyethylene glycol-based sealants, with
a trend toward decreased chest tube duration.22-24 Although
several commercially available polyethylene glycol-based
sealants have been shown to be efficacious in reducing post-
operative air leaks after lung surgery,25,26 the only Food and
DrugAdministration–approved pleural air leak sealant in the
United States is ProGEL (Neomend, Irvine, Calif), which
combines a mixture of polyethylene glycol and human
serum albumin. When applied, ProGEL forms a flexible
hydrogel matrix that can cover and seal areas of
parenchymal air leak. A prospective, randomized study has
demonstrated efficacy in the sealing of intraoperative air
leaks with ProGEL compared with controls and an
associated shorter hospital stay.27
Buttressing techniques have also been used in an attempt
to minimize the occurrence of postoperative air leaks. Sta-
ple line buttressing techniques include the use of pledgets,
bovine pericardium, and absorbable biosynthetic polyester
to reinforce the parenchymal line of transection. Initiallyery c September 2012
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vine pericardial strips has demonstrated efficacy in reducing
air leak severity.28 In a prospective, randomized study of pa-
tients undergoing unilateral lung reduction surgery, pericar-
dial strip buttressing was associated with a reduced duration
of postoperative air leaks and earlier chest tube removal.29
In another multicenter, randomized trial of patients under-
going pulmonary resection, pericardial reinforcement was
associated with a reduced air leak duration.30 A meta-
analysis of randomized, controlled trials examining the util-
ity of lung sealants and buttressing techniques found that
the use of these adjuncts was associated with a reduced in-
cidence of prolonged air leaks (>7 days) after lung surgery
(odds ratio, 0.55; 95% confidence interval, 0.39-0.79).31Conclusions
The published data regarding the use of tissue sealants
and buttressing techniques during lung surgery suggest
that these agents have the capacity to reduce the potential
for air leaks and their duration.
The authors wish to acknowledge the important contribution of
Margaret Reamer, Kimberly Burke, Lauren Matteo, Patricia Wil-
liams, and Maria Haffely for their assistance in organizing and an-
alyzing the hospital charts and providing timely updates regarding
patient follow-up data.References
1. Wilkins EW Jr, Scannell JG, Craver JG. Four decades of experience with resec-
tions for bronchogenic carcinoma at the Massachusetts General Hospital.
J Thorac Cardiovasc Surg. 1978;76:364-8.
2. Lewis RJ, Caccavale RJ, Sisler GE, Mackenzie JW. Video-assisted thoracic sur-
gical resection of malignant lung tumors. J Thorac Cardiovasc Surg. 1992;104:
1679-85.
3. Asamura H, Suzuki K, Kondo H, Tsuchiya R. Mechanical vascular division in
lung resection. Eur J Cardiothorac Surg. 2002;21:879-82.
4. Allen MS, Deschamps C, Lee RE, Trastek VF, Daly RC, Pairolero PC. Video-as-
sisted thoracoscopic stapled wedge excision for indeterminate pulmonary nod-
ules. J Thorac Cardiovasc Surg. 1993;106:1048-52.
5. Graeber GM, Collins JJH Jr, DeShong JL,Murray GF. Are sutures better than sta-
ples for closing bronchi and pulmonary vessels?AnnThorac Surg. 1991;51:901-5.
6. Szwerc MF, Landreneau RJ, Santos RS, Keenan RJ, Murray GF. Mini-thoracot-
omy combined with mechanically-stapled bronchial and vascular ligation for an-
atomical lung resection. Ann Thorac Surg. 2004;77:1904-9.
7. Entezari K, Hoffmann P, Goris M, Peltier A, Van Velthoven R. A review of cur-
rently available vessel sealing systems. Minim Invasive Ther Allied Technol.
2007;16:52-7.
8. Heniford BT, Matthews BD, Sing RF, Backus C, Pratt B, Greene FL. Initial re-
sults with an electrothermal bipolar vessel sealer. Surg Endosc. 2001;15:799-801.
9. Kennedy JS, Stranahan PL, Taylor KD, Chandler JG. High-burst-strength,
feedback-controlled bipolar vessel sealing. Surg Endosc. 1998;12:876-8.
10. Sugi K, Kaneda Y, Satoh Y, Murakami T. Effects of bipolar vessel sealing system
in pulmonary resections. Jpn J Thorac Surg. 2003;56:551-4.The Journal of Thoracic and Ca11. Lamberton GR, His RS, Jin DH, Lindler TU, Jellison FC, Baldwin DD. Prospec-
tive comparison of four laparoscopic vessel ligation devices. J Endourol. 2008;
22:2307-12.
12. Lacin T, Batirel HF, Ozer K, Demirutku A, Ahiskali R, YukselM. Safety of a ther-
mal vessel sealer on main pulmonary vessels. Eur J Cardiothorac Surg. 2007;31:
482-5.
13. Shigemura N, Akashi A, Nakagiri T, Ohta M, Matsuda H. A new tissue-sealing
technique using the Ligasure system for non-anatomical pulmonary resection:
preliminary results of sutureless and stapleless thoracoscopic surgery. Ann
Thorac Surg. 2004;77:1415-9.
14. Albanese CT, Sydorak RM, Tsao K, Lee H. Thoracoscopic lobectomy for pre-
natally diagnosed lung lesions. J Pediatr Surg. 2003;38:553-5.
15. Meehan JJ, Phearman L, Sandler A. Robotic pulmonary resections in children:
series report and introduction of a new robotic instrument. J Laparoendoscop
Adv Surg Techn. 2008;18:293-5.
16. Santini M, Vicidomini G, Baldi A, Gallo G, Laperuta P, Busiello L, et al. Use of
an electrothermal bipolar sealing system in lung surgery. Eur J Cardiothorac
Surg. 2006;29:226-30.
17. Schuchert MJ, Abbas G, Pettiford BL, Luketich JD, Landreneau RJ. Preliminary
results of anatomic lung resection using energy-based tissue and vessel coagula-
tive fusion technology. J Thorac Cardiovasc Surg. 2010;140:1168-73.
18. Brunelli A, Monteverde M, Borri A, Salati M, Marasco RD, Fianchini A. Predic-
tors of prolonged air leak after pulmonary lobectomy. Ann Thorac Surg. 2004;77:
1205-10.
19. Fleisher AG, Evans KG, Nelems B, Finley RJ. Effect of routine fibrin glue use on
the duration of air leaks after lobectomy. Ann Thorac Surg. 1990;49:133-4.
20. Wong K, Goldstraw P. Effect of fibrin glue in the reduction of post-thoracotomy
alveolar air leak. Ann Thorac Surg. 1997;64:979-81.
21. Belboul A, Dernevik L, Aljassim O, Skrbic B, Radberg G, Roberts D. The effect
of autologous fibrin sealant (Vivostat) on morbidity after pulmonary lobectomy:
a prospective, randomized, blinded study. Eur J Cardiothorac Surg. 2004;26:
1187-91.
22. Machiarini P, Wain J, Almy S, Dartevelle P. Experimental and clinical evaluation
of a new synthetic absorbable sealant to reduce air leaks in thoracic operations. J
Thorac Cardiovasc Surg. 1999;117:751-8.
23. Porte HL, Jany T, Akkad R, Conti M, Gillet PA, Guidat A, Wurtz AJ. Random-
ized, controlled trial of a synthetic sealant for preventing alveolar air leaks after
lobectomy. Ann Thorac Surg. 2001;71:1618-22.
24. Wain JC, Kaiser LR, Johnstone DW, Yang SC, Wright CD, Friedberg JS, et al.
Trial of a novel synthetic sealant in preventing air leaks after lung resection.
Ann Thorac Surg. 2001;71:1623-8.
25. D’Andrilli A, Andreetti C, Ibrahim M, Ciccone AM, Venuta F, Mansmann U,
et al. A prospective, randomized study to assess the efficacy of a surgical sealant
to treat air leaks in lung surgery. Eur J Cardiothorac Surg. 2009;35:817-21.
26. De Leyn P, Muller MR, Oosterhuis JWA, Schmid T, Choong CKC, Weder W,
et al. Prospective European multicenter randomized trial of PleuraSeal for con-
trol of air leaks after elective pulmonary resection. J Thorac Cardiovasc Surg.
2011;141:881-7.
27. Allen MS, Wood DE, Hawkinson RW, Harpole DH, McKenna RJ, Walsh GL,
et al. Prospective randomized study evaluating a biodegradable polymeric sealant
for sealing intra-operative air leaks that occur during pulmonary resection. Ann
Thorac Surg. 2004;77:1792-801.
28. Cooper JD. Technique to reduce air leaks after resection of emphysematous lung.
Ann Thorac Surg. 1994;57:1038-9.
29. Hazelrigg SR, Boley TM, Naunheim KS, Magee MJ, Lawyer C, Henkle JQ, et al.
Effect of bovine pericardial strips on air leak after stapled pulmonary resection.
Ann Thorac Surg. 1997;63:1573-5.
30. Miller JI Jr, Landreneau RJ, Wright CE, Santucci TS, Sammons BH. A compar-
ative study of buttressed versus non-buttressed staple line in pulmonary resec-
tions. Ann Thorac Surg. 2001;71:319-23.
31. Malapert G, Hanna HA, Pages PB, Bernard A. Surgical sealant for the prevention
of prolonged air leak after lung resection: meta-analysis. Ann Thorac Surg. 2010;
90:1779-85.rdiovascular Surgery c Volume 144, Number 3 S51
